Preliminary results of the rights offering
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA, HONG KONG OR JAPAN OR SUCH OTHER JURISDICTIONS WHERE THE OFFERING AND SALE OF THE NEW SHARES AND THE SUBSCRIPTION RIGHTS IS RESTRICTED BY LAW.
Reference is made to previous stock exchange announcements in relation to the rights offering of 100,000,000 offered shares in DiaGenic ASA at subscription price NOK 0.50 per share.
The subscription period for the rights offering ended 31 March 2014 and the preliminary subscription result shows that the rights offering was oversubscribed by approximately 140 per cent.
The allocation of offered shares is expected to take place on or about 4 April 2014, with payment for the allocated shares on 7 April 2014.
For further information, please contact:
Lars Christian Stugaard, Acting CEO, DiaGenic ASA, tel.: +47 23 01 49 06
This information is subject to the disclosure requirements acc. to §5-12 vphl (Norwegian Securities Trading Act)